Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus - Wikidata - awgldk - TriplyDB

Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus

Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus

http://www.wikidata.org/entity/Q33879348

about

Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C Virus

http://www.wikidata.org/entity/Q33879348

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@ast

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@en

type

label

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@ast

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@en

prefLabel

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@ast

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@en

P1433

Q33879348-C74A93C8-4078-4E6E-AB42-3BBD49FEDB89

P1476

Q33879348-BC288F56-A867-4D77-BF61-6AC92DA11948

P2093

Q33879348-69148BC9-8661-4B0E-8F29-348D5E73D605

Q33879348-6F71AF3E-9B89-428C-8207-F780B3E48CB0

Q33879348-8B4506B0-AEC3-4DB5-87DB-9F690ADC39A3

Q33879348-9A0BA42E-C3C8-4DAA-A212-A8F63266B79B

Q33879348-D64B7274-9E26-43F7-B7C2-92577C2A9407

P2860

Q33879348-0C8E3D12-9202-4F90-9D85-6499B6289D25

Q33879348-1AFC14C1-33E5-46F0-8F81-38EA324FB6E4

Q33879348-2BC08D96-4010-479D-AF00-BDE36BFFD131

Q33879348-2CA3E955-006A-42D6-93FE-A6E377E3021C

Q33879348-604D74A1-39F1-4F51-827C-DBD673CDC504

Q33879348-8B822316-7C11-4A74-BEDF-08BEEE34BA48

Q33879348-95C837EE-2AD9-41D3-A6D3-528CA1B5A640

Q33879348-BE8CEF58-CE5C-4FE4-BB35-529A62455E9F

Q33879348-DD2E1497-8E15-4611-99F3-9C4499F0E163

Q33879348-E16A0E61-B1E9-4AD3-8CF7-9BC737FCB6A1

P304

Q33879348-BBB99AC2-3F42-40C4-91F6-87367A307A85

P31

Q33879348-0D0D8C65-CC89-4AC7-B665-6CF8426FD743

P356

Q33879348-78A17533-D1CD-4AD6-9123-50F29E3ABED0

P433

Q33879348-A455E9EE-276B-4E07-A144-3A510C5D8282

P478

Q33879348-DD794F6B-EFE1-45C7-8AFB-3B8B4C2E7461

P50

Q33879348-3117FE5B-4AFB-4F2D-A672-95D5121157E9

P577

Q33879348-BEE6C693-B6B3-4DD7-8AF2-2A22D80039DD

P698

Q33879348-24C13AFB-76DE-48D9-BBB0-29B7FBA753AE

P921

Q33879348-9D96E1FB-ABD7-4F12-AE62-762A5AAE37D3

P932

Q33879348-ECA398FD-3AE3-41DA-A508-25568BC1D04A

P356

QMH.0000000000000137

P1433

Quality Management in Health Care

P1476

Evaluating a Collaborative App ...... Treatment of Hepatitis C Virus

@en

P2093

Darryn Potosky

http://www.w3.org/2001/XMLSchema#string

Emily E Dunn

http://www.w3.org/2001/XMLSchema#string

Janet Gripshover

http://www.w3.org/2001/XMLSchema#string

Kathryn Vranek

http://www.w3.org/2001/XMLSchema#string

Lauren M Hynicka

http://www.w3.org/2001/XMLSchema#string

P2860

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States

Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010

Physical, social, and psychological consequences of treatment for hepatitis C : a community-based evaluation of patient-reported outcomes.

Patient satisfaction with the clinical pharmacist and prescribers during hepatitis C virus management.

Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C.

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries.

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.

The Hepatitis C treatment experience: Patients' perceptions of the facilitators of and barriers to uptake, adherence and completion.

P304

136-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QMH.0000000000000137

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28665904

http://www.w3.org/2001/XMLSchema#string

P921

P932

5499965

http://www.w3.org/2001/XMLSchema#string